is imcivree a glp-1 IMCIVREE™ (setmelanotide) – The First FDA-Approved Therapy for Specific Rare Genetic Diseases of Obesity The application of GLP-1 receptor
Pay in 4 interest-free payments of $6.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


























